| Dr Eric J Lindstrom, MD | |
|
315 Holton Ave, Suite 102, Yakima, WA 98902-3254 | |
| (509) 248-6633 | |
| (509) 248-0178 |
| Full Name | Dr Eric J Lindstrom |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 315 Holton Ave, Yakima, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396794350 | NPI | - | NPPES |
| 748617841 | Medicaid | GA | |
| 2044744 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 057533 (Georgia) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD 60551281 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Memorial | Yakima, WA | Hospital |
| Astria Toppenish Hospital | Toppenish, WA | Hospital |
| Virginia Mason Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yakima Valley Radiology Inc Pc | 8527954312 | 6 |
| Virginia Mason Medical Center | 9830002617 | 825 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication.
What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma - and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more.
› Verified 2 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication.
What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma - and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more.
› Verified 2 days ago
| Entity Name | Yakima Valley Radiology Inc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871524827 PECOS PAC ID: 8527954312 Enrollment ID: O20040227000149 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication.
What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma - and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric J Lindstrom, MD Po Box 2925, Yakima, WA 98907-2925 Ph: (509) 248-6633 | Dr Eric J Lindstrom, MD 315 Holton Ave, Suite 102, Yakima, WA 98902-3254 Ph: (509) 248-6633 |
News Archive
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication.
What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma - and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more.
› Verified 2 days ago
Joseph P Gouveia, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 315 Holton Ave Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-248-0733 | |
William C Feldmann, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-248-0733 | |
Daniel Pak, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave, Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-248-0733 | |
Sean F Cleary, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 808 N 39th Ave, Yakima, WA 98902 Phone: 509-574-3500 | |
Dr. Gregory Alan Wright, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 315 Holton Ave Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-895-0402 | |
David C Stepanek, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-248-0733 | |
William J Glenski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave Ste 102, Yakima, WA 98902 Phone: 509-895-0402 Fax: 509-248-0733 |